EP3438096 - Bibliographic data
PROCÉDÉ DE FABRICATION DE LA 1-(ARYLMÉTHYL) QUINAZOLINE-2,4(1H, 3H)-DIONE
| Last update | 17/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
IMPACT THERAPEUTICS, INC Room 603, No.3 Building
111 Xiangke Road
China (Shanghai) Pilot Free Trade Zone
Shanghai 201210
Chine
|
|---|---|
| (72) Inventors |
Suixiong CAI Room 901
No. 14 Building
573 Bibo Road
Shanghai 201203
Chine
Ping HUANG Room 301
No. 7 Building
90 Delin Road
Pudong New District
Shanghai 200131
Chine
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP17773281.5 |
|---|---|
| (22) Request date | 31/03/2017 |
| (11) Publication number | EP3438096 |
|---|---|
| Publication date | 02/12/2020 |
| (54) Title of the invention | PROCÉDÉ DE FABRICATION DE LA 1-(ARYLMÉTHYL) QUINAZOLINE-2,4(1H, 3H)-DIONE |
|---|---|
| (51) International classification | C07D 239/96 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201610202881 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 6 -
Amount: 125 € -
Due date 31/03/2022
Surtax: 6 - Amount: 25 € - Due date 03/10/2022 |
|---|---|
| Last annuity | Annuity: 5 - Payment date 04/03/2021 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 02/12/2020 Constitution de mandataire pour un dossier - Legal date 03/03/2021 Entrée en période de grâce du brevet d'invention - Legal date 01/04/2022 Génération de l'avertissement avant déchéance - Legal date 25/04/2022 Déchéance du brevet d'invention après période de grâce - Legal date 31/03/2022 |